Partners Group Reshapes Fund Line-Up as London Trust Heads for Wind-Down

Partners Group plans a twin-track overhaul: splitting its EUR 6.6bn evergreen fund while a listed trust moves to run-off after a 74% realisation vote.

Partners Group is pressing ahead with a twin-track overhaul of its investment vehicles, splitting its flagship evergreen fund while simultaneously preparing to liquidate a London-listed trust whose shareholders have effectively voted down a planned restructuring.

At the centre of the asset manager's plans is the Global Value SICAV, a vehicle with a net asset value of EUR 6.6 billion. Partners Group intends to convert it into a fund-of-funds structure built around two separate sub-portfolios, each tailored to a different investor profile. One sleeve would be accumulating and geared toward long-term capital growth; the other would distribute income, funnelling proceeds from future asset sales back to investors. The reorganisation still hinges on shareholder approval.

Parmaco Sale Under Review

Running alongside the fund architecture work, the Swiss firm is weighing portfolio disposals. Bloomberg reported on 30 September that Partners Group, working with Bank of America, is exploring a sale of Finnish modular builder Parmaco. The Scandinavian portfolio company could command an enterprise value of roughly EUR 1.5 billion — a deal that would unlock liquidity potentially recyclable into the broader portfolio structure.

Pressure has also been building at a separate vehicle. At Partners Group Private Equity Limited, the independently listed entity, shareholders elected to convert 48,829,366 shares — 74.12% of the issued stock — into realisation shares. That decisively cleared the 40% threshold, rendering the previously proposed reorganisation moot. Investors at an extraordinary general meeting on 7 October 2026 will now be asked only to approve an orderly run-off of the portfolio. The measure applies specifically to the listed subsidiary and does not directly affect Partners Group Holding AG.

A Partners Group spokesman attributed the looming dissolution to structural challenges facing listed fund formats, Bloomberg reported. Several holdings in the trust's portfolio had already weighed on results, including write-downs on Emeria and Ammega and a full write-off of its stake in pharmaceutical company Pharmathen.

Analysts Trim Their Targets

The repositioning and market backdrop are reflected in how research houses are sizing up the stock. Jefferies cut its price target for Partners Group on 29 September to CHF 605 from CHF 710, keeping a "Hold" rating. The analysts pointed to delays in the recovery of assets under management and difficulties in the evergreen structures segment. UBS had already lowered its own target more than a month earlier.

Trading has mirrored this mix of operational friction and a demanding environment. The stock last closed at EUR 652.00, leaving it down 39% year to date and still hovering near its 52-week low of EUR 623.00. Whether the split of the flagship vehicle can generate fresh momentum now rests on investor consent.